Abstract
In-stent restenosis (ISR) is a persistent problem limiting the long-term success of percutaneous coronary intervention. Recent studies have demonstrated safety and efficacy of drug-eluting balloon (DEB) angioplasty for the treatment of coronary ISR. The cost-effectiveness of this practice is unknown
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
